References: 1. BEPREVE [package insert]. Tampa, FL: Bausch & Lomb Incorporated.
2019. 2. Muñoz M, Williams JI, Gow JA, Schooley GL, McNamara TR; for the
Bepotastine Ophthalmic Solutions Clinical Study Group. Bepotastine besilate ophthalmic solution 1.5%
provides a rapid and sustained reduction in ocular itch for severely allergic subjects following
exposure to ragweed or grass pollens using the conjunctival allergen challenge (CAC) model of allergic
conjunctivitis. Poster presented at: 2011 Annual Scientific Meeting of the American College of Allergy,
Asthma & Immunology; November 3-8, 2011; Boston, MA. Poster P341.